Meningitis Vaccines Market: By Vaccines - (Polysaccharide Vaccines, Conjugate Vaccines, and Combination Vaccines); By Product - (Meningitis A+C, Meningitis ACWY135, and Meningitis B); By Diseases Type - (Viral Meningitis, Bacterial Meningitis, Meningococc

Life Science

Request PDF Sample Request Free Customization
  • Status : Ongoing
  • Published on: Feb 2021
  • Report ID: KDMI-5431
  • Available Format: PDF/Excel/DOC


Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Meningitis Vaccines Market

Request Sample

Industry Insights

The meningitis vaccines market is anticipated to flourish at a CAGR of 13.8% over the forecast period i.e. 2020-2025. Further, the market for meningitis vaccines was valued at USD XXX.X Million in 2019.

Growth Drivers – Meningitis Vaccines Market

Increasing Cases of Meningitis vaccines

Increasing incidence of indications of many meningitis vaccines and rising old age population of the globe is a major growth driver of global meningitis vaccines market. Further, it is anticipated that number of patients living with OA is anticipated to increase by 10.1% during 2019-2025. This factor is further expected to strengthen the growth of global meningitis vaccines market.
26 African countries in “meningitis belt” is going through various mass campaigns and achieving higher coverage rates. Moreover, various countries in Africa had introduced meningococcal A conjugate vaccine through mass campaigns in the past three years.

Market Growth to Come from Developing Nations

Entry of new products in the market is set to drive the market growth during the forecast period. Various major market players are focusing on introduction and expansion of their product portfolio. Further, development of new drugs helps to cure the diseases more effectively and are witnessing widescale adoption in various nations.

Barriers – Meningitis Vaccines Market

High Cost of Meningitis Vaccine

Factors such as high cost of vaccines, lack of awareness and low diagnosis rate in developing and under-developed nations are anticipated to hamper the growth of global meningitis vaccine market.

Segmentation Analysis

The meningitis vaccines market by vaccines is segment into polysaccharide vaccines, conjugate vaccines and combination vaccines. The market for polysaccharide vaccines is anticipated to witness significant growth during the forecast period. Factors such as growing usage of meningitis vaccines in children is anticipated to drive the growth global meningitis vaccines market.
Further, global meningitis vaccines market is also segmented by diseases type into viral meningitis, bacterial meningitis, meningococcal disease, pneumococcal meningitis, TB meningitis, fungal meningitis, Hib meningitis and others. Bacterial meningitis segment captured significant market share during the forecast period. Further, viral meningitis segment is anticipated to witness highest growth in the upcoming years.

Geographical Analysis

Geographically, the report offers analysis of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In meningitis vaccines market, North America captured the largest percentage of market in global meningitis vaccines market. With a market share of approximately 41.3% in 2019, U.S. market contributed majorly in global meningitis vaccines market. It is anticipated that one in four adults are diagnosed with rheumatic disorder in America. Addition to that, favorable government policies is envisioned to bolster the growth of global meningitis vaccines market. Asia Pacific meningitis vaccines market is anticipated to witness robust growth during the forecast period. Base of large patient population and rising government focus to boost healthcare in the region is anticipated to impel the growth of Asia Pacific meningitis vaccines market.

Competitive Landscape

The report profiles various major market players such as;

- AbbVie
- Amgen
- Johnson & Johnson
- Novartis
- Pfizer
- Roche
- Eli Lilly
- Bristol-Myers Squibb
- Other Major & Niche Players

Competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as financial information, revenue breakup by segment and by geography, SWOT Analysis, key facts, company overview, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, technology development, research & development and other market activities).
The study also provides company’s positioning and market share in meningitis vaccines market.

Timeline Considered for Analysis:

- 2014 to 2018: Historical Review
- 2020: Base Year
- 2020 to 2025: Forecast Period

Research Scope and Deliverables

Overview & Executive Summary
Market Drivers, Trends, Challenges and Opportunities
Market Size and Forecast Projections
Macroeconomic Indicators of Various Countries Impacting the Growth of the Market
Extensive Coverage of Industry Players including Recent Product Launches and Market Activities
Porter’s Five Force Analysis
Market Segmentation Analysis:
Industry report analyzes the global meningitis vaccines market by the following segments:
- Site of Action
- Application

Customization: We also offers customization’s in the industry report as per the company’s specific needs.

Key Questions Answered in the Global Meningitis Vaccines Industry Report:

- What is the overall market size in 2019? What will be the market growth during the forecast period i.e. 2020-2025?
- Which region would have high demand for product in the upcoming years?
- What are the factors driving the growth of the market?
- Which sub-market will make the most significant contribution to the market?
- What are the market opportunities for existing and entry-level players?
- What are various long-term and short-term strategies adopted by the market players?


Custom Research Requirement? Questions to ask?

Get in touch

Custom Research requirement.

Go Up